Left ventricular mass as a predictor of cardiovascular events in the era of hypertension management using home blood pressure measurement: the J-HOP study

被引:0
作者
Hirotaka Waki
Satoshi Hoshide
Kazuomi Kario
机构
[1] Jichi Medical University School of Medicine,Division of Cardiovascular Medicine, Department of Medicine
来源
Hypertension Research | 2022年 / 45卷
关键词
Home blood pressure; Target organ damage; Left ventricular mass index; Cardiovascular event;
D O I
暂无
中图分类号
学科分类号
摘要
Target organ damage (TOD) is associated with a risk of cardiovascular disease (CVD) independent of blood pressure (BP); however, this association has been observed based on the assessment of office BP. We studied 1641 patients (mean age 64.8 ± 11.7 years) with CVD risk factors who underwent home BP measurement over a 14-day period and evaluated TOD at baseline and then performed follow-up examination of the J-HOP (Japan Morning Surge-Home Blood Pressure) study results. During the median follow-up of 6.6 ± 3.5 years, 115 participants experienced a CVD event. After adjustment for CVD risk factors, including office systolic BP, the adjusted hazard ratios expressing the risk of CVD events were 1.30 (95% confidence interval, 1.15–1.52), 1.27 (1.04–1.56), and 1.25 (1.11–1.40) per one-SD increase in log-transformed urinary albumin creatinine ratio (UACR, 0.57 mg/gCre), brachial-ankle pulse wave velocity (baPWV, 342 cm/s) and left ventricular mass index (LVMI, 26.6 g/m2) assessed by echocardiography, respectively. Even after adding home systolic BP as a covariate, these associations remained except for the association with baPWV (all P < 0.05). The C-statistic for the base model including office and home systolic BP for the risk of CVD events was 0.783 (95% CI: 0.743, 0.824), which significantly increased to 0.795 (95% CI: 0.757, 0.834) after adding LVMI, and changed slightly but not significantly with the addition of UACR or baPWV. Adding UACR, baPWV, or both to the model including LVMI did not improve CVD event prediction. In the modern era of hypertension management using home BP measurement, TOD indicators, especially LVMI, provide superior CVD event prediction independent of and beyond home BP.
引用
收藏
页码:1240 / 1248
页数:8
相关论文
共 184 条
[1]  
Whelton PK(2018)2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Hypertension 71 e13-e115
[2]  
Carey RM(2018)2018 ESC/ESH Guidelines for the management of arterial hypertension Eur Heart J 39 3021-104
[3]  
Aronow WS(2019)The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) Hypertens Res 42 1235-481
[4]  
Casey DE(1998)Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan J Hypertens 16 971-5
[5]  
Collins KJ(2005)Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice J Hum Hypertens 19 801-7
[6]  
Dennison Himmelfarb C(2010)Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study Hypertension 55 1346-51
[7]  
Williams B(2016)Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the Japan Morning Surge-Home Blood Pressure Study Hypertension 68 54-61
[8]  
Mancia G(2019)Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes JAMA 322 409-20
[9]  
Spiering W(2019)Measurement of blood pressure in humans: a scientific statement from the American Heart Association Hypertension 73 e35-e66
[10]  
Agabiti Rosei E(2021)Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension J Hypertens 39 1742-67